Search results
Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Park National Corp OH
ETF DAILY NEWS· 6 days agoPark National Corp OH lowered its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 17.7% during the first quarter, according to its most recent ...
Bristol Myers' (BMY) Krazati Gets FDA Nod for Colorectal Cancer
Zacks via Yahoo Finance· 5 hours agoBristol Myers (BMY) wins FDA approval for Krazati, in combination with Erbitux, as a targeted...
Park Avenue Securities LLC Grows Position in Bristol-Myers Squibb (NYSE:BMY)
ETF DAILY NEWS· 3 days agoPark Avenue Securities LLC raised its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 30.8% during the first quarter, according to its most recent ...
Better High-Yield Dividend Stock: Pfizer vs. Bristol Myers Squibb
The Motley Fool via AOL· 6 days agoIt has a diverse product portfolio spanning various therapeutic areas, including but not limited to...
Bristol-Myers Squibb Declares Quarterly Dividend of $0.60 (NYSE:BMY)
ETF DAILY NEWS· 7 days agoInvestors of record on Friday, July 5th will be given a dividend of 0.60 per share by the biopharmaceutical company on Thursday, August 1st. Bristol-Myers ...
StockNews.com Downgrades Bristol-Myers Squibb (NYSE:BMY) to Buy
ETF DAILY NEWS· 6 days agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) was downgraded by research analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a ...
3 No-Brainer Stocks to Buy for Under $100 Right Now
Motley Fool via Yahoo Finance· 3 days agoGranted, there are some reasons for Pfizer's low valuation. Sales of the company's COVID-19 products are sinking like a brick. Like Bristol< ...
Pipeline Moves: Approval prospects for BioTissue’s diabetic foot ulcer drug up after Phase III...
Clinical Trials Arena via Yahoo Finance· 15 hours agoThe Connecticut, US-headquartered company released a press release announcing the Phase I trial...
Therapy developer Alumis seeks up to $1 billion valuation in US IPO
WSAU Wausau· 11 hours ago(Reuters) - Alumis is targeting a valuation of up to $1.01 billion in its initial public offering in the United States, the therapy developer said on Monday. Biotech IPOs have shown signs of ...
7 Dividend Stocks to Buy Now: June 2024
InvestorPlace· 1 day agoThese dividend stocks to buy now will reward investors with income now and growth as the market breadth expands.